What Is Autonomix Medical, Inc. (AMIX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Autonomix Medical, Inc.'s intrinsic value is estimated at a composite $9.54, showing conflicting signals at the current price of $5.75. While the average implied return is +65.9%, model disagreement is elevated with a gap of +342.9% between the most bullish and bearish estimates. The most optimistic model, CUCE, places fair value at $19.79 (+244.1%), while ML-RIV — the most conservative — estimates $0.07 (-98.8%). This +342.9% gap reflects genuine analytical uncertainty about Autonomix Medical, Inc.'s intrinsic worth.
What Do the Models Say About AMIX?
6 of 13 models are currently active for AMIX. Of these, 3 models suggest upside while 3 models suggest overvaluation. The Bayesian DCF estimates AMIX's intrinsic value at $12.46, implying +116.8% upside from the current price. See which stocks rank higher →
How Does AMIX Rank in Medical Devices?
Among 10 Medical Devices stocks, AMIX ranks #8 by Quality of Company score. CirclFi's QOC score of 4.1/10 evaluates 32 fundamental signals. A score of 4.1 reflects mixed fundamentals.
As a pharmaceutical industry, Autonomix Medical, Inc. operates in a sector where patent cliff exposure is a critical driver of valuation. Investors evaluating AMIX should weigh these sector-specific dynamics alongside our model-derived fair values.
Is AMIX a Value Trap?
CirclFi's Value Trap algorithm assigns AMIX a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
6 of 13 models are active for Autonomix Medical, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Autonomix Medical, Inc.'s fundamental quality profile registers 4.1/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +342.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every AMIX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across AMIX's 6 active models, average confidence is 21%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad